Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
Primary Industries
- Drugs
- Cancer
- Diagnostic
- Disease
- DNA
- Assay
- Instruments
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 209521
Licensor grants a worldwide, nonexclusive license, with no right to grant sublicenses, under Licensor Alliance Patent Rights and Licensor’s Deliverable Alliance Technology solely to the extent necessary to permit Licensee and its Affiliates to Commercialize Non-Alliance Products.
Licensor grants a worldwide, nonexclusive license, with no right to grant sublicenses, under Licensor Independent Patent Rights and under Independent Technology that was previously used by Licensee or its Affiliates in Commercialization of an Alliance Product, solely to the extent necessary to permit Licensee and its Affiliates to Commercialize Non-Alliance Products that had been subject to rejected NPCDs (New Product Concept Document) in the Conditionally Exclusive Areas.
For Outside the Alliance Field, for products, other than therapeutic products, Licensor grants a nonexclusive license under Licensor’s Deliverable Alliance Technology and any Licensors Alliance Patent Rights, to manufacture, use, sale, offer for sale or import of which is covered by a Valid Claim of the Licensors Alliance Patent Rights
The Licensor grants licenses of the scope granted under the corresponding Independent Technology and Alliance Technology Copyrighted Works that are part of Joint Alliance Technology.
Copyrighted Works means original works of authorship, including, without limitation, computer programs (in source code, object code or other form), notes, sketches, drawings and reports.
IPSCIO Record ID: 211130
Licensor grants to a worldwide, nonexclusive license, with no right to grant sublicenses, under Licensor Alliance Patent Rights and Deliverable Alliance Technology solely to the extent necessary to permit Licensee and its Affiliates to Commercialize Non-Alliance Products.
Licensor grants a worldwide, nonexclusive license, with no right to grant sublicenses, under Licensor Independent Patent Rights and under Independent Technology that was previously used by Licensee or its Affiliates in Commercialization of an Alliance Product, solely to the extent necessary to permit Licensee and its Affiliates to Commercialize Non-Alliance Products that had been subject to rejected NPCDs (New Product Concept Document) in the Conditionally Exclusive Areas. The license granted in this Section will survive expiration or termination of this Agreement.
For Outside the Alliance Field, for products, other than therapeutic products, Licensor grants a nonexclusive license, under Licensors Deliverable Alliance Technology and any Licensor Alliance Patent Rights.
IPSCIO Record ID: 273391
Diagnostic Service(s) shall mean the performance of laboratory-based assays covered in whole or in part by a Valid Claim of the Patent Rights.
Gene Patent Rights shall mean the United States and foreign patents and patent applications relating to the APC (Adenomamus polyposis coli) gene and/or the p53 gene and licensed (with the right to grant sublicenses) to Licensor pursuant to the JHU (Johns Hopkins University) License Agreement together with patents arising therefrom and any extensions, registrations, confirmations, reissues, divisions, continuations or continuations-in-part, re-examinations or renewals thereof, including without limitation the patents and patent applications listed hereto (which may be updated from time to time to include such additional patents and patent application that may arise therefrom); provided, however, that Gene Patent Rights expressly excludes any claims of such patents and patent applications that fall outside of the Field, including, without limitation, claims to antibodies, to the treatment, prevention or remedying of a gene deficiency, to purified proteins, or to DNA (Deoxyribonucleic acid) sequences other than those sequences that correspond to the p53 gene and the APC (Adenomatous polyposis coli) gene; provided further that DNA sequences which are (i) immediately adjacent to the p53 or APC genes and (ii) necessary to the use of the p53 or APC genes, respectively, in the Field shall be considered within the Gene Patent Rights.
US Patent No. 5,352,775 – APC gene and nucleic acid probes derived therefrom
US Patent No. 5,527,676 – Detection of loss of the wild-type P53 gene and kits therefor
Methodology Patent Rights shall mean the United States and foreign patents and patent applications relating to methods of detecting mammalian nucleic acids isolated from stool specimens and reagents therefor and licensed (with the right to grant sublicenses) to Licensor pursuant to the JHU (Johns Hopkins University) License Agreement together with patents resulting therefrom and any extensions, registrations, confirmations, reissues, divisions, continuations or continuations-in-part, re-examinations or renewals thereof, including without limitation the patents and patent application listed hereto (which may be updated from time to time to include such additional patents and patent applications that may arise therefrom).
US Patent Application No. W093/20235 and 08/861,910 (detecting mammalian nucleic acids from stool)
Licensed Reagent shall mean any Reagent covered in whole or in part by a Valid Claim of the Patent Rights.
Kit shall mean a collection of one or more Reagents, including at least one Licensed Reagent, packaged in the form of a kit (including an FDA Approved kit).